Literature DB >> 26189123

Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis.

Simone Longhi, Massimiliano Lorenzini, Christian Gagliardi, Agnese Milandri, Antonio Marzocchi, Cinzia Marrozzini, Francesco Saia, Paolo Ortolani, Elena Biagini, Pier Luigi Guidalotti, Ornella Leone, Claudio Rapezzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26189123     DOI： 10.1016/j.jcmg.2015.04.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  28 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

2.  Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging.

Authors:  Elisa Merli; Eleonora Del Giudice; Athanassios Antonopoulos; Gianadrea Amadei; Elisabetta Varani
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-02       Impact factor: 2.357

3.  State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis.

Authors:  Vasvi Singh; Rodney Falk; Marcelo F Di Carli; Marie Kijewski; Claudio Rapezzi; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2018-12-19       Impact factor: 5.952

4.  Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis.

Authors:  João L Cavalcante; Shasank Rijal; Islam Abdelkarim; Andrew D Althouse; Michael S Sharbaugh; Yaron Fridman; Prem Soman; Daniel E Forman; John T Schindler; Thomas G Gleason; Joon S Lee; Erik B Schelbert
Journal:  J Cardiovasc Magn Reson       Date:  2017-12-07       Impact factor: 5.364

5.  Prognostic Value of Computed Tomography-Derived Extracellular Volume in TAVR Patients With Low-Flow Low-Gradient Aortic Stenosis.

Authors:  Balaji Tamarappoo; Donghee Han; Jeffrey Tyler; Tarun Chakravarty; Yuka Otaki; Robert Miller; Evann Eisenberg; Siddharth Singh; Takahiro Shiota; Robert Siegel; Jasminka Stegic; Tracy Salseth; Wen Cheng; Damini Dey; Louise Thomson; Daniel Berman; John Friedman; Raj Makkar
Journal:  JACC Cardiovasc Imaging       Date:  2020-10-28

6.  Impact of flow, gradient, and left ventricular function on outcomes after transcatheter aortic valve replacement.

Authors:  Edward T Carreras; Tsuyoshi Kaneko; Fernando Ramirez-Del Val; Marc P Pelletier; Piotr S Sobieszczyk; Deepak L Bhatt; Pinak B Shah
Journal:  Catheter Cardiovasc Interv       Date:  2017-10-08       Impact factor: 2.692

Review 7.  Cardiac Amyloid - An Update.

Authors:  Jason N Dungu
Journal:  Eur Cardiol       Date:  2015-12

8.  Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.

Authors:  Ramsey M Wehbe; Preeti Kansal; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2020-05-07       Impact factor: 5.952

9.  Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.

Authors:  Adam Castaño; David L Narotsky; Nadira Hamid; Omar K Khalique; Rachelle Morgenstern; Albert DeLuca; Jonah Rubin; Codruta Chiuzan; Tamim Nazif; Torsten Vahl; Isaac George; Susheel Kodali; Martin B Leon; Rebecca Hahn; Sabahat Bokhari; Mathew S Maurer
Journal:  Eur Heart J       Date:  2017-10-07       Impact factor: 29.983

Review 10.  Updates in Cardiac Amyloidosis Diagnosis and Treatment.

Authors:  Lily K Stern; Michelle M Kittleson
Journal:  Curr Oncol Rep       Date:  2021-03-16       Impact factor: 5.075
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.